Sellas Life Sciences Group (SLS) Stocktwits Mentions Statistics 2025

153 125%

1W 14.2% 1M 168.4% 3M 68.1%

Est. daily mentions on Stocktwits.

Similar companies

Company		Stocktwits Mentions
	Amgen AMGN	5 0%
	Gilead Sciences GILD	4 20%
	Catalyst Pharmaceuticals CPRX	2 0%
	Inovio Pharmaceuticals INO	30 42.9%
	Anavex Life Sciences AVXL	68 5.6%

Month over Month

Est. daily mentions on Stocktwits.

Dec 2024	68	24.4%
Nov 2024	55	6.7%
Oct 2024	59	21.6%
Sep 2024	75

How often is Sellas Life Sciences Group mentioned on StockTwits?

Sellas Life Sciences Group was mentioned an estimated 153 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Sellas Life Sciences Group performing compared to its industry peers?

Compared to its peers, Sellas Life Sciences Group ranks in the 55th percentile when it comes to Stocktwits Mentions.

What does a high frequency of StockTwits mentions indicate for Sellas Life Sciences Group's market sentiment?

A high frequency of mentions on StockTwits for Sellas Life Sciences Group could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Sellas Life Sciences Group's stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Sellas Life Sciences Group's mentions on StockTwits?

AltIndex updates the data on Sellas Life Sciences Group's mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Sellas Life Sciences Group's on the platform.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.